View more job listings or post a job
Jazz Pharmaceuticals Senior Manager, Clinical Pharmacology
Nektar Therapeutics Research Associate III
Nektar Therapeutics Sr. Scientist, Bioanalytical
Genentech, Inc. Associate Scientist/Scientist, Drug Metabolism and Pharmacokinetics
Jubilant Discovery Services Senior Manager Business Development
Aimmune Therapeutics The Associate Director, Quality Control will be a key member of the analytical team and he/she will support activities associated with quality control activities of Aimmune’s APIs and drug products conducted at CTL/CMO.  
Precision for Medicine Senior Manager, Quality Assurance
Denali Therapeutics Bioanalytical Research Scientist, DMPK (SM/Biomarker)
Arena Pharmaceuticals The Principal Scientist will report to the Head of Analytical Sciences and will serve as the analytical lead in cross-functional product development tea
Genentech Associate Scientist/Scientist, Process Analytical Technology, Small Molecule Analytical Chemistry  
Post a job


Physiologically Based Pharmacokinetic (PBPK) Modeling: Fundamentals, Regulatory Guidance & Applications

Speakers: Yuan Chen (Genentech), Michael Bolger (Simulations Plus), Sebastian Polak (Certara), Susie Zhang (FDA), Ying Ou (BeiGene), Venkatesh Pilla Reddy (AstraZeneca), Tycho Heimbach (Novartis)
Organizers: Yuan Chen (Genentech), Tracy Chen (Jazz), Snow Ge (Nektar), Ying Ou (BeiGene)
Date: 2019-10-18
Time: 8:45-17:00 Pacific Time
Registration fee (USD): Regular - Full Day: $195; Regular - Morning Only: $125; Regular - Afternoon Only: $125; Academic: $125; For unemployed or students: $35; For vendor-show rep: $35; For major-sponsor rep (incl lunch): $0
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (1)Catalent Pharma Solutions;(Major Sponsorship - afternoon session still open)
Vendor show vendors registered to date: (3)MicroConstants; Pion Inc.; SEKISUI XenoTech
Registration deadline:2019-10-16  (it will close sooner if the seating cap is reached)

About the Topic

Physiologically based pharmacokinetic (PBPK) models have been widely used at various stages of drug product development and regulatory review for different purposes, such as predicting absorption, distribution, metabolism and excretion (ADME), assessing drug-drug interaction (DDI) potentials, providing mechanistic explanation to PK characteristics, and predicting pharmacokinetics (PK) in specific populations.

Workshop Agenda

8:45am - 8:55am        PBSS Welcome - Shichang Miao

Morning Session        PBPK:  Overview of Basic Knowledge and Applications 

8:55am - 9:15am        1. Overview of Basic Knowledge in PBPK - Yuan Chen (Genentech)

9:20am - 10:20am      2. PBPK Concept and Application -  Absorption Prediction - Michael Bolger (Simulations Plus)

10:20am - 10:30am    Major Sponsor Presentation - Catalent

10:30am - 10:45am    Break  

10:45am - 12:00pm    3. PBPK Concept and Application -  DDI & PK in special population.- Sebastian Polak

12:00pm - 1:00pm      Lunch 

Afternoon Session      PBPK:  Role in drug development and regulatory filing by case examples

1:00pm - 1:30pm        1. PBPK in Regulatory Science: An Update From the FDA and overview of PBPK guidance  - Susie Zhang (FDA)

1:30pm - 2:00pm        2. PBPK Model Qualification and Reporting procedure for Regulatory Submission: A Consortium Perspective  - Yuan Chen (Genentech)

2:00pm – 2:45pm       3. PBPK Modeling and simulation to predict transporter mediated drug-drug interactions: are we there yet?  - Venkatesh Pilla Reddy (AstraZeneca)

2:45pm - 2:55pm        Major Sponsor Presentation - TBD

2:55pm – 3:15pm       Break & Raffle

3:15pm – 4:00pm       4. Impact of PBPK Models on Regulatory Reviews and Product labels: Complex DDI, PPI and Oral Contraceptives - Ying Ou (BeiGene)

4:00pm - 4:45pm        5. PBPK Modelling of Renal and Hepatic Organ Impairment, and  pediatric population -A Pharmaceutical Industry Perspective  and regulatory experience - Tycho Heimbach (Novartis)

5:00pm - 5:30pm        Panel Discussion - All speakers

2019-11-12, Antibody Drug Discovery and Development: Hit Generation, Engineering, Cell-line Development, IND enabling studies, and Biosimilars
2019-12-10, In Vitro Diagnostics (IVD), Companion Diagnostics (CDx) and Precision Medicine
2020-01-10, All about half-life: which one should I use? (tentative title)
2020-01-21, Considerations for Successful Clinical Development: Fundamentals and Best Practices for Clinical Trial Design, Biostatistics, and Data Management
2020-02-11, Development of Drug/Device Combinations
2020-02-24, MS Courses by Dr. Jack Henion: Advanced LC-MS/MS (Day1) & Interpretation of MS/MS CID Spectra (Day2)
2020-03-16, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2020-04-10, Biopolymer-based conjugation of therapeutic proteins and antibodies for improving drug properties (tentative title)
2020-05-12, Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
2020-05-22, No More Undruggables: Unconventional Approaches for Drug Discovery and Design - prodrugs, PROTACS, fragment-based design, directed evolution and beyond
2020-06-23, Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)
┬ęPharmaceutical & BioScience Society, International; Last Modified: 10/20/2019; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

BIOTECH WEEK BOSTON - Sept. 9-12 Access over 5,000 of the most innovative scientific minds & business leaders in Boston and around the world. Learn More.
Origin Bioanalytical Laboratory Sacramento-based CRO for bioanalytical method development, validation, and consulting of LC-MS/MS analysis, specializing in ocular matrices
UC Davis UC Davis LC/MS Confirmation Supervisor (Lab Rsch Supv 2) Apply Online: UC Davis is an AA/EOE
Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS & GC-MS/MS bioanalytical quantitation services of small & large molecules in any matrix. Discovery through phase IV.
XCELERATE at Biotech Week Boston Driving the Future of the Life Science Industry. Sept. 11 at BCEC. Learn more.
Adesis Inc. Adesis provides expertise in custom synthesis, process dev, R&D, and specialty mfg. to pharma, chemical, biomaterials, and catalysts companies
Submit a Text Ad